IMPURITIES AVAILABLE FOR 'Ombitasvir'

Omsynth Lifesciences Pvt. Ltd. is one of the leading manufacturer and exporter of Ombitasvir. Ombitasvir is a direct-acting antiviral agent (DAA) used in combination with other drugs for the treatment of chronic hepatitis C virus (HCV) infection. It works as an NS5A inhibitor, blocking a viral protein essential for RNA replication and virion assembly, thereby suppressing HCV replication. Ombitasvir is part of fixed-dose combination regimens, such as with paritaprevir, ritonavir, and dasabuvir, targeting multiple stages of the viral life cycle. It is administered orally, usually once daily with food. The drug is highly protein-bound and metabolized in the liver, primarily excreted via bile. Ombitasvir is effective against several HCV genotypes (especially 1 and 4). Common side effects include fatigue, nausea, pruritus, and insomnia. It should be used cautiously in patients with moderate to severe hepatic impairment. Combination therapy with ombitasvir achieves high sustained virologic response (SVR) rates. Buy high quality Ombitasvir from Omsynth Lifesciences.